These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8427659

  • 21. Commentary on Shigetomi and Kuchel's work on DOPA decarboxylation.
    Zimlichman R.
    Am J Hypertens; 1993 Jan; 6(1):89-90. PubMed ID: 8427668
    [No Abstract] [Full Text] [Related]

  • 22. Effects of water immersion on sympathoadrenal and dopa-dopamine systems in humans.
    Grossman E, Goldstein DS, Hoffman A, Wacks IR, Epstein M.
    Am J Physiol; 1992 Jun; 262(6 Pt 2):R993-9. PubMed ID: 1535759
    [Abstract] [Full Text] [Related]

  • 23. Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.
    Mars H.
    Arch Neurol; 1974 Jun; 30(6):444-7. PubMed ID: 4827061
    [No Abstract] [Full Text] [Related]

  • 24. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
    de Toledo FG, Thompson MA, Bolliger C, Tyce GM, Dousa TP.
    Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
    [Abstract] [Full Text] [Related]

  • 25. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
    Brown MJ, Dollery CT.
    Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of thyroid hormone on the renal dopaminergic system.
    Del Compare JA, Aguirre JA, Ibarra FR, Barontini M, Armando I.
    Endocrine; 2001 Aug; 15(3):297-303. PubMed ID: 11762703
    [Abstract] [Full Text] [Related]

  • 31. Heart failure, aging, and renal synthesis of dopamine.
    Ferreira A, Bettencourt P, Pestana M, Correia F, Serrão P, Martins L, Cerqueira-Gomes M, Soares-Da-Silva P.
    Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
    [Abstract] [Full Text] [Related]

  • 32. Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to salt-resistant subjects.
    Damasceno A, Santos A, Serrão P, Caupers P, Soares-da-Silva P, Polónia J.
    J Hypertens; 1999 Dec; 17(12 Pt 2):1995-2001. PubMed ID: 10703901
    [Abstract] [Full Text] [Related]

  • 33. [Dopamine and hypertension].
    Sigetomi S, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1993 Oct 20; 69(9):953-62. PubMed ID: 8262273
    [Abstract] [Full Text] [Related]

  • 34. Modulation of natriuresis and renal dopamine excretion by sympathetic activity and the renin-angiotensin-aldosterone system.
    Barendregt JN, van Nispen tot Pannerden LA, Chang PC.
    J Hum Hypertens; 1994 Oct 20; 8(10):747-54. PubMed ID: 7837211
    [Abstract] [Full Text] [Related]

  • 35. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
    Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen NJ.
    Acta Neurol Scand; 1995 Aug 20; 92(2):116-21. PubMed ID: 7484057
    [Abstract] [Full Text] [Related]

  • 36. Dopamine deficiency--its potential contribution to chronic renal failure complicating hypertension.
    Kuchel O, Shigetomi S.
    Hypertens Res; 1995 Jun 20; 18 Suppl 1():S183-5. PubMed ID: 8529056
    [Abstract] [Full Text] [Related]

  • 37. Involvement of tubular sodium in the formation of dopamine in the human renal cortex.
    Soares-da-Silva P, Pestana M, Fernandes MH.
    J Am Soc Nephrol; 1993 Mar 20; 3(9):1591-9. PubMed ID: 8507815
    [Abstract] [Full Text] [Related]

  • 38. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L, Deng M, Zhang S, Fang Y, Li L.
    Clin Exp Pharmacol Physiol; 2014 Sep 20; 41(9):685-90. PubMed ID: 24910244
    [Abstract] [Full Text] [Related]

  • 39. Dopa, catecholamines and their metabolites in essential hypertension.
    Januszewicz W, Wocial B.
    Clin Sci Mol Med Suppl; 1975 Jun 20; 2():295s-298s. PubMed ID: 1077780
    [Abstract] [Full Text] [Related]

  • 40. The adrenal glands as suppliers of plasma L-Dopa and sources of urinary dopamine.
    Hansell P, Källskog O, Wolgast M.
    Kidney Blood Press Res; 1996 Jun 20; 19(2):109-14. PubMed ID: 8871890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.